From the Author
When White Lodge firstpublished this book in the late 1980s and it was selling well, my Mondaymorning was spoiled on receiving a letter from attorneys for an American druggiant threatening me with a $10 million lawsuit for alleged defamation. I wasconfident that I had a good defence to the allegations and so did thepublishers.
Unfortunately when Ijetted over to the FDA archives outside Washington DC, the records on which Ihad relied had been removed (presumed stolen). Senator Edward Kennedy couldhave been a good witness on my behalf but he declined to get involved. Suchrecords as I had were then supplied to an expert in the UK who fell onto arailway track in London and the documents were blown away. (There must beanother thriller in what really happened involving the expert!).
Along with thepublishers, we were left defenceless and rather than write a cheque for $10million from the petty cash, we had to surrender and the book was withdrawnfrom the selling outlets. No Amazon or e-books in those days!
I'm delighted to see TheDallas Dilemma once again available. The words alleged to be defamatory havebeen deleted but everything else remains and I'm delighted that Endeavour Pressare now publishing once again.
The story of Lusifren, afictitious drug created by a fictitious drug company remains a compelling storyof some of the dirty tricks that have been prevalent in the industry.